The Effects of Timolol On Healing and Cosmesis of Mohs Scalp Wounds: An Open Label Trial

Trial statusNot yet recruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorGeisinger Clinic

About this trial

The goal of this study clinical trial is to learn if topical timolol can accelerate healing and improve the cosmetic appearance of surgical wounds on the scalp following Mohs surgery. It will include Geisinger patients 18 year or older who undergo Mohs surgery of the scalp with planned wound healing by secondary intent. The main questions in aim to answer are:

1. Compare wound healing speed between patients treated with topical timolol and those receiving standard wound care only. 2. Compare cosmetic outcomes using topical timolol and standard wound care. 3. Evaluate the impact of topical timolol on the number of unplanned follow-up visits and calls related to delayed wound healing.

Participants will be asked use either topical timolol or use standard wound care to treat their Mohs surgery scalp wound. They will follow-up around 4, 8 and 12 weeks.

Eligibility criteria

Qualifiers

None

Disqualifiers

Known allergy or sensitivity to timolol or any components of the study medication.

Bronchial asthma or history of bronchial asthma

Severe chronic obstructive pulmonary disease (COPD)

Sinus bradycardia

Trial design

Treatments tested in this trial

  • Topical Timolol
  • Normal Saline

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators